MENU
Aim higher

OligoG

Alginate derived oligosaccharide G-block as a new drug candidate in the treatment of cystic fibrosis.

OligoG is a new, inhaled dual-acting drug candidate developed from alginate. It is being developed for the treatment of cystic fibrosis. This project aims to progress the project until end of phase 2 and to evaluate lung deposition of OligoG using gamma scintigraphy and pharmacokinetic profiling.
Acronym: 
OligoG
Project ID: 
6 628
Ranking: 
27
Cut-off: 
6
Start date: 
01-09-2011
Project Duration: 
39months
Project costs: 
4 375 180.00€
Technological Area: 
Clinical Research, Trials
Market Area: 
Therapeutic